Atara Biotherapeutics, Inc. (ATRA)
8.59
-0.84
(-8.91%)
USD |
NASDAQ |
Oct 23, 16:00
8.64
+0.05
(+0.58%)
After-Hours: 20:00
Atara Biotherapeutics Price : 8.59 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 9.37 | 9.37 | 8.55 | 8.59 | 24320.00 |
| Oct 22, 2026 | 9.23 | 9.65 | 8.971 | 9.43 | 23018.00 |
| Oct 21, 2026 | 9.25 | 9.43 | 9.17 | 9.35 | 26543.00 |
| Oct 20, 2026 | 8.89 | 9.29 | 8.88 | 9.16 | 14846.00 |
| Oct 19, 2026 | 9.03 | 9.35 | 8.96 | 8.96 | 12450.00 |
| Oct 16, 2026 | 9.67 | 9.905 | 9.18 | 9.18 | 19493.00 |
| Oct 15, 2026 | 9.35 | 9.78 | 9.185 | 9.65 | 24451.00 |
| Oct 14, 2026 | 9.29 | 9.990 | 9.20 | 9.56 | 39955.00 |
| Oct 13, 2026 | 9.25 | 9.54 | 8.80 | 9.305 | 32286.00 |
| Oct 12, 2026 | 9.42 | 9.58 | 8.99 | 9.38 | 26837.00 |
| Oct 09, 2026 | 9.33 | 9.560 | 9.33 | 9.48 | 22149.00 |
| Oct 08, 2026 | 9.42 | 9.42 | 8.82 | 9.23 | 28942.00 |
| Oct 07, 2026 | 9.62 | 9.750 | 9.37 | 9.37 | 11449.00 |
| Oct 06, 2026 | 9.41 | 9.79 | 9.05 | 9.75 | 47598.00 |
| Oct 05, 2026 | 9.59 | 9.63 | 8.95 | 9.40 | 39319.00 |
| Oct 02, 2026 | 8.46 | 9.675 | 8.25 | 9.48 | 85752.00 |
| Oct 01, 2026 | 8.73 | 9.20 | 8.23 | 8.46 | 90929.00 |
| Sep 30, 2026 | 8.08 | 8.710 | 7.83 | 8.50 | 29302.00 |
| Sep 29, 2026 | 8.33 | 8.821 | 7.89 | 8.05 | 56451.00 |
| Sep 28, 2026 | 8.69 | 8.705 | 8.336 | 8.37 | 23529.00 |
| Sep 25, 2026 | 8.60 | 8.99 | 8.535 | 8.81 | 31197.00 |
| Sep 24, 2026 | 8.60 | 8.86 | 8.33 | 8.54 | 20777.00 |
| Sep 23, 2026 | 8.92 | 8.95 | 8.40 | 8.56 | 40473.00 |
| Sep 22, 2026 | 9.30 | 9.60 | 8.93 | 8.93 | 27265.00 |
| Sep 21, 2026 | 9.69 | 9.92 | 9.30 | 9.38 | 29670.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 19.73 |
| Alnylam Pharmaceuticals, Inc. | 224.03 |
| Anika Therapeutics, Inc. | 21.42 |
| Savara, Inc. | 4.22 |
| Vericel Corp. | 42.53 |
Price Related Metrics
| PS Ratio | 17.34 |
| PEG Ratio | -0.0268 |
| Earnings Yield | -16.28% |
| Market Cap | 81.12M |
| PEGY Ratio | -0.0268 |